BI Dashboards & Analytics for Pharmaceuticals & Life Sciences

Two reports disagreeing about revenue destroys confidence in the whole platform. A semantic layer with agreed definitions is what prevents that, and it is a governance decision as much as a technical one.

In pharmaceuticals & life sciences, GxP validation means every system change needs documented evidence before it reaches production. That single fact reshapes how bi dashboards & analytics has to be built here, the guardrails, the approval points and the evidence trail are design inputs rather than things bolted on before go-live.

The workload we are most often asked to take on first is deviation and CAPA drafting, usually integrated against eTMF. Integration comes before intelligence. A model that cannot reach your systems of record is a demo with good manners.

Deployed across regulated and unregulated sectors, with audit trails where the regulator expects them. You own the code, the models where they are open-weight, and the documentation to run it without us.